Pre-market analysis

1)Nifty closed at 9914.0 up 1.02% and banknifty closed at 20296.70 up 1.93%.

2)Today, US and Europe futures are trading lower and asian markets opened falt to small negative and sgx nifty is trading at 9834.5 down 0.71%.

4) We may open gap down of around 100-120 pts due to indo china tension and will once again follow global futures as the day progresses.

5)This will key to watch for banks today.
SC hearing on interest on Moratorium case today. 
Remember SC had observed that complete interest waiver on COVID moratorium is not feasible. But said charging interest on the Interest on Moratorium could be looked at. 
Banks-RBI are not in favor

6)India-china border clash - Any News on this can create volatality.

7)Support and resistance for Nifty and Banknifty  for intraday.
8)Nifty option pain is at 9900 and banknifty option pain is at 20100.

9)Nifty may trade between 10000 and 9500 ramge for this week and banknifty may trade between 21000 and 19000 range for this week as per option chain which will act as good resistance and support.

10)Results today.
IGL
ABAN
CUMMINSIND
CYBERTECH
EMKAY
FDC
FORTIS
GULFOILLUB
HEG
ITDCEM
JKCEMENT
KANORICHEM
LINKPH
MANGLMCEM
MOLDTEK
NATCOPHARM
NAVNETEDUL
PIDILITIND

11)Stocks in news.
Banks/NBFC -Due to sc hearing.

Cadila/wockhardt/Pharma cos
Reports suggest dexamethasone can reduce deaths by one-third in critical Covid patients
In News 

HDFC AMC 
Standard life to sell up to 2.72% stake in AMC via OFS

EMAMI
Covid-19 Update Yesterday Post Market
COVID-19 pandemic would impact the Company's business performance in QIFY21 
Operations are expected to normalize Q2FY21 onwards.
Co’s healthcare range has witnessed a steady demand for its immunity boosting products

AARTI DRUGS / HIKAL
India may impose anti-dumping duty on Chinese antibacterial drug Ciprofloxacin Hydrochloride
Aarti Drugs Limited had filed the application for imposition of anti-dumping duty on imports of the medicine from China.

12)Results 
HPCL Q4 QoQ
Net Profit At `26.8 Cr Vs  `747.2 Cr
Revenue (RD)6.5% At `66,154.9 Cr Vs  `70,749 Cr 
EBITDA Loss At `706.6 Cr Vs EBITDA Of  `1,863.3 Cr
Tax credit at 2461cr vs tax expense at 404cr
GRM, January-March 2020 (YoY) (-)$1.23/barrel Vs $4.51/barrel

NMDC Q4
Misses estimates Cons YoY
Net Profit (RD)78% At `315.4 Cr Vs `1,448.9 Cr
Revenue (RD)12.5% At `3,187.3 Cr Vs `3,643.3 Cr
EBITDA (RD)28.8% At `1,487.7 Cr Vs `2,090.4 Cr
EBITDA Margin At 46.7% Vs 57.4%

Navin Fluorine 
Q4FY20-YoY
Reported PAT higher due to tax reversal of 222cr
Revenue up 10% at 276cr vs 252cr
EBITDA up 34% at 69cr vs 51.5cr
OPM at 25% vs 20.4%
PAT at 270cr vs 33.5cr
Tax reversal at 222cr
Adjusted pat at 48cr vs 33.5cr

Globus Spirits
Q4FY20 YOY
Revenue flat at Rs.271cr vs 271.6cr
Gross margins at 42% vs 35%
EBITDA up 91% at Rs.35.3cr vs 18.4cr
Margins at 13% vs 6.8% 
PAT at Rs.19.35cr vs 5.01cr

13)F&O BAN
Enters Ban: JINDALSTEL 
Still in Ban: ADANIENT, IDEA, JUSTDIAL
Out of Ban: BHEL

14)Happy trading.Follow our telgram channel for calls on equity and options -Optionstraders


















Comments

Popular posts from this blog

Trading Strategies Series Part 6

Pre-market analysis

Pre-market analysis